Millions of people take medication to protect their bones, but a new safety update in Spain has highlighted an unusual risk associated with a commonly prescribed osteoporosis treatment. Spain’s medicines agency, AEMPS, has updated its safety information on alendronate following reports of atypical fractures, including some occurring after minor injuries or without obvious trauma.
Source